Merck Introduces Bron-Newcavac-SE for Control of Salmonella07 November 2012
US - Merck Animal Health has announced the introduction of Bron-Newcavac-SE, an effective, long-lasting vaccine to control Newcastle disease, infectious bronchitis and Salmonella enteritidis – a serious threat to the poultry industry and human health.
“Salmonella is one of the most common food-borne, disease-causing bacteria and can pose significant risks to humans. Given the potential health threat the bacteria poses, commercial egg-laying operators are keenly aware of how vital it is to have a strong, FDA-compliant Salmonella enteritidis control program in place,” says Charles Broussard, D.V.M, MAM, Merck Animal Health.
“Producers need to be confident in their Salmonella enteritidis vaccine and Bron-Newcavac-SETM is a convenient, three-way product that helps ensure their flock, workers and operation are protected and that they are in full compliance with FDA regulations.”
In addition to controlling Salmonella enteritidis, Bron-Newcavac-SE controls the respiratory pathogens that cause Newcastle disease and infectious bronchitis when administered to chickens 10 weeks of age or older, as well as supports strong flock uniformity. Bron-Newcavac-SE is also a strong complement to the company’s existing portfolio of innovative poultry health solutions, which include products to address intestinal health, respiratory protection and dynamic immunity.
“We know the impact of Salmonella enteritidis, Newcastle disease and infectious bronchitis, as well as a multitude of other health issues, can be devastating for a poultry producer,” says Dr Broussard. “That’s why we are committed to providing our customers with the products, resources and support they need to help protect our food supply, meet regulatory guidelines and be successful in an ever-changing industry. It’s how we support ‘The Science of Healthier Animals’ every day.”
Further ReadingFind out more information on the diseases mentioned in this article by clicking here.
|ThePoultrySite News Desk||More Merck Animal Health News|